E71.40
Disorder of carnitine metabolism, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Disorders of carnitine metabolism are rare metabolic conditions that affect the body's ability to process and utilize carnitine, a crucial nutrient involved in energy production within cells. Specifically, the ICD-10 code E71.40 pertains to an unspecified disorder of carnitine metabolism, highlighting cases where the exact nature or cause of the disorder is not clearly defined. Carnitine plays an essential role in transporting long-chain fatty acids into the mitochondria, the energy-producing structures within cells, making it vital for proper metabolic functioning. When this process is disrupted, it can lead to a variety of health issues, particularly affecting the muscles and the heart.
Causes & Symptoms
Clinical Causes: Genetic mutations that impair the synthesis or transport of carnitine Secondary causes such as certain medications or underlying metabolic disorders Nutritional deficiencies, though rare in developed countries Acquired conditions leading to increased loss or impaired utilization of carnitine
Key Symptoms: Muscle weakness or fatigue Cardiomyopathy (heart muscle disease) Enlarged liver (hepatomegaly) Hypoglycemia (low blood sugar) Difficulty feeding in infants Exercise intolerance Muscle pain or cramps
Diagnostic & Treatment
Diagnosis Path: Diagnosing a disorder of carnitine metabolism involves a combination of clinical evaluations and laboratory tests. Blood and urine analyses are used to measure levels of free and acylcarnitine, which can reveal abnormalities indicative of the disorder. In some cases, genetic testing is performed to identify specific mutations associated with carnitine metabolism issues. Additional assessments might include muscle biopsies or metabolic studies to evaluate mitochondrial function and demonstrate impaired fatty acid oxidation.
Treatment Protocols: Carnitine supplementation to replenish deficient levels Dietary adjustments to include appropriate nutrients and avoid fatty acids that the body can't process effectively Monitoring and managing symptoms such as muscle weakness or heart problems Regular follow-up with healthcare providers to assess metabolic status and adjust treatment as needed Addressing any underlying or secondary causes if identified
Clinical Advice & FAQs
Billing Guidance
Is E71.40 a billable ICD-10 code?
Yes, E71.40 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E71.40?
Clinical documentation must specify the nature of Disorder of carnitine metabolism, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference